Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab +/- Tremelimumab plus Chemotherapy in mNSCLCS. Peters,B. C. Cho,A. Luft, J. Alatorre-Alexander,S. L. Geater,S. -W. Kim, G. Ursol,M. Hussein, F. L. Lim, C. -T. Yang, L. H. Araujo, H. Saito,N. Reinmuth, R. Stewart,Z. Lai, R. Doake,L. Krug,E. B. Garon,T. Mok,M. L. JohnsonJOURNAL OF THORACIC ONCOLOGY（2022）引用 2|浏览21暂无评分关键词STK11, KRAS, POSEIDONAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
